Etiometry Earns Top Honors – Major Recognition Nearby and Nationally
News and Press Releases
BOSTON, December 17, 2018 – Improving the quality of critical care has always been their top priority but earning accolades along the way is an added bonus. In 2018, Etiometry earned major recognition and funding from prestigious organizations nearby and nationally.
Competing against 213 companies from five of the six New England states can be a daunting task for any business owner; but Etiometry was up for the challenge. After narrowing the competition to 50 semi-finalists, then 20 finalists, Etiometry’s COO Evan Butler presented the company’s mission in front of a 64-judge panel. Several months of deliberation went by but, ultimately, Etiometry took top honors as one of the eight winners of the 2018 New England Business Association’s Innovation Awards. “As the Circle of Excellence welcomes the class of 2018, I can honestly say it is one of our best yet”, said New England Innovation Awards Committee Chairman, Todd Faber, President, The Faber Group, in a press release.
The largest source of funding for medical research in the world continues to see value in Etiometry’s work. For the third time in four years, The National Institutes of Health awarded Etiometry nearly one million dollars to continue their groundbreaking progress in dynamic analytics for critical care facilities. The latest grant award aims to investigate how Etiometry’s FDA-cleared Risk Analytics Algorithm for Inadequate Delivery of Oxygen, known as the IDO2 Index, can best be used to inform treatment decisions. With the help of their clinical partners, the team is designing and deploying protocols and studying their critical care outcomes; such as length of stay, time on ventilation, and ECMO events. As a Boston-based company, Etiometry is proud to contribute to the city’s unparalleled 23-year record for most NIH funds.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
Why Measuring Key Clinical Markers Matters in Cardiogenic Shock
Cardiogenic shock (CS) remains a critical issue in hospitals nationwide. Despite advances in interventional cardiology, CS is a high-mortality condition, with mortality ranges from 30% to 40%, and 1-year mortality approaches or exceeds 50%. One of the main challenges is the rapid progression of CS severity. Historically, staging using the Society for Cardiovascular Angiography and […]
Why Conventional EHR Systems Are Insufficient for Shock Detection
Cardiogenic shock (CS) remains a critical and life-threatening condition, characterized by a rapid decline in cardiac function and multi-organ dysfunction, often leading to high mortality rates. Despite advancements in critical care, its intricate and rapidly evolving nature presents a formidable clinical challenge. Early identification and prompt intervention are paramount for improved patient outcomes. However, the […]
Three Practical Steps to Improve Institutional Readiness for Cardiogenic Shock
Cardiogenic shock (CS) represents a profound and often fatal complication in hospitalized patients, with short-term mortality rates persisting at a concerning 40% to 50%. Despite significant advancements in cardiovascular critical care and interventional cardiology, its intricate and rapidly evolving nature continues to present a formidable clinical challenge. Crucially, the initial manifestations of CS are frequently […]